Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07201402 · ClinicalTrials.gov registry record · Phase 2
Long Term Evaluation of Scapular-inserted Contraceptive Implants
A Phase 2 study, sponsored by Yale University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 62
- Enrollment target
NCT07201402: Recruiting Phase 2 study, sponsored by Yale University.
NCT07201402 is a Phase 2 study that is actively recruiting participants, run by Yale University. The registered enrollment target is 62 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07201402, a Phase 2 study, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 62 participants
- Enrollment target
Study Summary
This study aims to evaluate long-term outcomes when the etonogestrel contraceptive implant is inserted at an alternative site located over the scapular. The study will evaluate the pharmacokinetics (i.e., drug levels) and side effect profiles of participants who have an etonogestrel contraceptive implant inserted at this alternative scapular site over the course of at least two years.
Primary Outcome
Serum etonogestrel concentrations measured using a validated LC-MS assay
Interventions
- DRUG Scapular-site insertion of etonogestrel contraceptive implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2026-05-08 |
| Est. Completion | 2027-10 |
| Phase | Phase 2 |
What NCT07201402 shows while recruiting
NCT07201402 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 1 intervention - of which Scapular-site insertion of etonogestrel contraceptive implant is the first listed.
NCT07201402 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07201402 about?
NCT07201402 is a clinical study titled "Long Term Evaluation of Scapular-inserted Contraceptive Implants". This study aims to evaluate long-term outcomes when the etonogestrel contraceptive implant is inserted at an alternative site located over the scapular. The study will evaluate the pharmacokinetics (i.e., drug levels) and side effect profiles of participants who have an etonogestrel contraceptive im...
What is the current status of trial NCT07201402?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 62 participants. The study started on 2026-05-08. Estimated completion is 2027-10.
What interventions are being tested in trial NCT07201402?
The interventions under investigation include: Scapular-site insertion of etonogestrel contraceptive implant (DRUG).
Who is sponsoring clinical trial NCT07201402?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07201402's enrollment target sits among peer trials
62 1016th of 2000 higher than 975 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI